中外医学研究
中外醫學研究
중외의학연구
CHINESE AND FOREIGN MEDICAL RESEARCH
2014年
20期
53-53,54
,共2页
前列地尔%阿托伐他汀%下肢动脉硬化闭塞症
前列地爾%阿託伐他汀%下肢動脈硬化閉塞癥
전렬지이%아탁벌타정%하지동맥경화폐새증
Alprostadil%Atorvastatin%Arteriosclerosis obliterans
目的:探讨前列地尔联合阿托伐他汀治疗下肢动脉硬化闭塞症的临床研究。方法:选取2010年5月-2013年7月笔者所在医院收治的140例下肢动脉硬化闭塞症患者,采用随机数字表法将其分为联合组与对照组,各70例。对照组给予前列地尔治疗,联合组在此基础上联合应用阿托伐他汀治疗,比较两组临床疗效及不良反应发生情况。结果:联合组临床总有效率88.6%明显高于对照组的78.6%,差异有统计学意义(字2=4.627,P=0.016<0.05)。联合组不良反应发生率7.1%与对照组的5.7%比较,差异无统计学意义(P>0.05)。结论:前列地尔联合阿托伐他汀治疗下肢动脉硬化闭塞症安全有效,值得在临床上推广使用。
目的:探討前列地爾聯閤阿託伐他汀治療下肢動脈硬化閉塞癥的臨床研究。方法:選取2010年5月-2013年7月筆者所在醫院收治的140例下肢動脈硬化閉塞癥患者,採用隨機數字錶法將其分為聯閤組與對照組,各70例。對照組給予前列地爾治療,聯閤組在此基礎上聯閤應用阿託伐他汀治療,比較兩組臨床療效及不良反應髮生情況。結果:聯閤組臨床總有效率88.6%明顯高于對照組的78.6%,差異有統計學意義(字2=4.627,P=0.016<0.05)。聯閤組不良反應髮生率7.1%與對照組的5.7%比較,差異無統計學意義(P>0.05)。結論:前列地爾聯閤阿託伐他汀治療下肢動脈硬化閉塞癥安全有效,值得在臨床上推廣使用。
목적:탐토전렬지이연합아탁벌타정치료하지동맥경화폐새증적림상연구。방법:선취2010년5월-2013년7월필자소재의원수치적140례하지동맥경화폐새증환자,채용수궤수자표법장기분위연합조여대조조,각70례。대조조급여전렬지이치료,연합조재차기출상연합응용아탁벌타정치료,비교량조림상료효급불량반응발생정황。결과:연합조림상총유효솔88.6%명현고우대조조적78.6%,차이유통계학의의(자2=4.627,P=0.016<0.05)。연합조불량반응발생솔7.1%여대조조적5.7%비교,차이무통계학의의(P>0.05)。결론:전렬지이연합아탁벌타정치료하지동맥경화폐새증안전유효,치득재림상상추엄사용。
Objective:To study Clinical studies alprostadil with atorvastatin in patients with arteriosclerosis obliterans treated. Method:140 cases of lower extremity arteriosclerosis obliterans from May 2010 to July 2013 in author’s hospital,were randomly divided into combined group and control group,70 cases in each.The control group received alprostadil treatment group on this basis,combined with atorvastatin treatment,incidence rate of two groups of clinical curative effect and adverse reaction.Result:Combined with clinical total effective rate of 88.6%was significantly higher than the control group 78.6%,the difference was statistically significant (χ2=4.627,P=0.016<0.05). Compared with the group of adverse reaction was 7.1%and 5.7%in the control group,no significant difference (P>0.05).Conclusion:Alprostadil combined with atorvastatin treatment of lower extremity arterial occlusive disease,should be introduced in clinical practice.